by Stacey Johnson | Sep 16, 2016
September is Sepsis Awareness Month and World Sepsis Day was acknowledged earlier this week – on Tuesday, September 13. That’s why there’s a good possibility that you have seen the video below, about a heartbroken mother who lost her young son to sepsis. (It has...
by David Kent | Aug 2, 2016
Last week, a good friend of mine forwarded me a correspondence from the New England Journal of Medicine (NEJM). I was expecting to read about a new drug being tested in clinical trials or maybe a neat scientific perspective on leukemia biology, but what I got instead...
by Stacey Johnson | Jul 29, 2016
It was Science magazine’s 2013 breakthrough of the year and called a “turning point in cancer.” It even scored its own awareness month that year. Cancer immunotherapy – therapies that harness the power of a patient’s immune system to fight their disease – had...
by Holly Wobma | Jul 28, 2016
The summer 2016 Olympics are rapidly approaching and I’ve already been blown away by preview clips of some of the competing athletes performing amazing (and kind of dangerous!) looking stunts. Clouding this year’s games, however, has been the Zika virus outbreak, for...
by Mark Curtis | Jun 30, 2016
Welcome to your update from the clinic for the month of May. Long-standing industry pioneer StemCells, Inc. decided to wind down its operations after a failed Phase 2 study in spinal cord injury. Aduro Biotech also saw a failure with its GVAX product in pancreatic...
by Mark Curtis | Jun 23, 2016
Welcome to your deal review for the month of May. Intellia Therapeutics went public this past month giving investors a second shot on net if they want to gain exposure to gene editing technologies. Caladrius Biosciences spun-out its cell-based immunotherapy to AiVita...
Comments